Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP) Cash flow

11 Followers

Beximco Pharmaceuticals Limited Sponsored GDR RegS Cash Flow

GB:BXP's free cash flow for Q2 2023 was $997.78M. For the 2023 fiscal year, GB:BXP's free cash flow was decreased by $-3.07B and operating cash flow was $―. See a summary of the company’s cash flow.

Cash Flow	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Operating Cash Flow	$ 6.08B	$ 15.08B	$ 6.02B	$ 5.54B	$ ―
Investing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
Financing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
End Cash Position	$ ―	$ ―	$ ―	$ ―	$ ―
Free Cash Flow	$ 3.55B	$ 6.62B	$ ―	$ ―	$ ―